CEMI News and Press, Chembio Diagnostics Inc. From 07/20/21

Gainers: NeuroMetrix (NURO) +161%.NeuroBo Pharmaceuticals (NRBO) +45%.LSB Industries (LXU) +35%.Staffing 360 Solutions (STAF) +24%.Endo International plc (ENDP) +23%.Pop Culture Group (CPOP) +23%.Immunome (IMNM) +19%.Ideal Power (IPWR) +19%.Femasys (FEMY) +16HCA Healthcare (HCA) +15%.Los...

Gainers: NeuroMetrix (NURO) +161%.NeuroBo Pharmaceuticals (NRBO) +45%.LSB Industries (LXU) +35%.Staffing 360 Solutions (STAF) +24%.Endo International plc (ENDP) +23%.Pop Culture Group (CPOP) +23%.Immunome (IMNM) +19%.Ideal Power (IPWR) +19%.Femasys (FEMY) +16HCA Healthcare (HCA) +15%.Los...

Chembio Diagnostics Inc. (NASDAQ:CEMI) traded today at a new 52-week low of $2.40. This new low was reached on below average trading volume as 115,000 shares traded hands, while the average 30-day volume is approximately 531,000 shares. Chembio Diagnostics Inc is a company that develops,...

Shares of Chembio Diagnostics Inc. (NASDAQ:CEMI) traded today at $2.66, breaking its 52-week low. So far today approximately 115,000 shares have been exchanged, as compared to an average 30-day volume of 533,000 shares. Potential upside of 20.9% exists for Chembio Diagnostics Inc., based...

Chembio Diagnostics Inc. (NASDAQ:CEMI) traded at a new 52-week low today of $2.83. So far today approximately 115,000 shares have been exchanged, as compared to an average 30-day volume of 448,000 shares. Chembio Diagnostics Inc is a company that develops, manufactures, and commercialize...

Shares of Chembio Diagnostics Inc. (NASDAQ:CEMI) traded today at $2.81, breaking its 52-week low. This new low was reached on below average trading volume as 115,000 shares traded hands, while the average 30-day volume is approximately 448,000 shares. Chembio Diagnostics Inc is a company...

Shares of Chembio Diagnostics Inc. (NASDAQ:CEMI) traded at a new 52-week low today of $2.83. So far today approximately 115,000 shares have been exchanged, as compared to an average 30-day volume of 448,000 shares. Over the past year, Chembio Diagnostics Inc. has traded in a range of $2....

Chembio Diagnostics (CEMI): Q1 GAAP EPS of -$0.22 beats by $0.10.Revenue of $8.72M (+27.1% Y/Y) beats by $0.53M.Press Release For further details see: Chembio Diagnostics EPS beats by $0.10, beats on revenue

HAUPPAUGE, N.Y., May 06, 2021 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today reported financial results for the quarter ended March 31, 2021. Chembio achieved first quarter 2021 total revenue of...

(Polina Tankilevitch/Pexels) (The Street) — Precipio (NASDAQ:PRPO) skyrocketed Monday after the specialty diagnostics company said it had launched its COVID-19 ...